← All trials
NCT04421339
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2020
- Primary completion
- Jan 1, 2021
- Completion date
- Jul 1, 2021
- First posted
- Jun 9, 2020
- Last posted
- Jun 9, 2020
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Texas at HoustonLead sponsor
- University of Texas at HoustonReponsible party - principal investigator
- University of Texas at HoustonOverall official - principal investigator
- Huntington's Disease Society of AmericaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.